机译:ASX11AS11,DNMT3A DNMT3A,JAK2 JAK2,TET2 TET2,TP53 TP53和NPM1 NPM1对新诊断的急性髓性白血病患者结果的影响
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of BiostatisticsThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas;
acute myeloid leukemia; ASXL1; DNMT3A; JAK2; TET2; TP53;
机译:ASX11AS11,DNMT3A DNMT3A,JAK2 JAK2,TET2 TET2,TP53 TP53和NPM1 NPM1对新诊断的急性髓性白血病患者结果的影响
机译:骨髓增生性肿瘤中ASXL1,CBL,DNMT3A,IDH1,IDH2,JAK2,MPL,NF1,SF3B1,SUZ12和TET2的突变分析
机译:继发性急性髓细胞性白血病长期缓解后真性红细胞增多症的DNMT3A,TET2和JAK2突变
机译:骨髓增生异常综合症和急性髓细胞性白血病中ASXL1CBLFLT3IDH1IDH2JAK2KRASNPM1NRASRUNX1TET2和WT1基因的组合突变
机译:XL1,DNMT3A,JAK2,TET2,TP53,ANDNPM1,新诊断的急性髓性白血病患者的结果对XL1,DNMT3A,JAK2,TET2,ANDNPM1的影响